The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2016 | B-cell receptor and function in CLL
Francesco Forconi, MD, PhD from the University of Southampton, Southampton, UK gives an overview of his talk on the structure and function of the B-cell receptor in chronic lymphocytic leukemia (CLL) held at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark. Dr Forconi also outlines why changes in the characteristics of the B-cell receptor affect the function and behavior of the tumor as well as how to target the receptor.
